Regulation of PHLDA1 Expression by JAK2-ERK1/2-STAT3 Signaling Pathway
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of PHLDA1 Expression by JAK2-ERK1/2-STAT3 Signaling Pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 117, Issue 2, Pages 483-490
Publisher
Wiley
Online
2015-08-04
DOI
10.1002/jcb.25296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STAT1 plays a role in TLR signal transduction and inflammatory responses
- (2014) Kevin Luu et al. IMMUNOLOGY AND CELL BIOLOGY
- Mechanisms of Jak/STAT Signaling in Immunity and Disease
- (2014) Alejandro V. Villarino et al. JOURNAL OF IMMUNOLOGY
- Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells
- (2013) Alain Zgheib et al. CYTOKINE
- The Role of JAK-3 in Regulating TLR-Mediated Inflammatory Cytokine Production in Innate Immune Cells
- (2013) H. Wang et al. JOURNAL OF IMMUNOLOGY
- The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation
- (2013) Daniel J. Gough et al. PLoS One
- Deficiency of TDAG51 Protects Against Atherosclerosis by Modulating Apoptosis, Cholesterol Efflux, and Peroxiredoxin‐1 Expression
- (2013) Gazi S. Hossain et al. Journal of the American Heart Association
- TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production
- (2012) Melanie Manetsch et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Loss of TDAG51 Results in Mature-Onset Obesity, Hepatic Steatosis, and Insulin Resistance by Regulating Lipogenesis
- (2012) Sana Basseri et al. DIABETES
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Role of JAK2-STAT3 in TLR2-mediated tissue factor expression
- (2012) Dae-Weon Park et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer
- (2011) E. O. Johnson et al. JOURNAL OF CELL SCIENCE
- PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma
- (2010) K. Sellheyer et al. BRITISH JOURNAL OF DERMATOLOGY
- Growth Hormone and Insulin-Like Growth Factor I Insensitivity of Fibroblasts Isolated from a Patient with an IκBα Mutation
- (2010) Shufang Wu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
- (2010) C. J. Greenhill et al. JOURNAL OF IMMUNOLOGY
- STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria
- (2009) Lobelia Samavati et al. MOLECULAR IMMUNOLOGY
- TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation
- (2008) Michael D Oberst et al. BMC CANCER
- Transcriptional up-regulation of PHLDA1 by 17β-estradiol in MCF-7 breast cancer cells
- (2008) A.C. Marchiori et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Bacterial ligand of TLR2 signals Stat activation via induction of IRF1/2 and interferon-α production
- (2008) Mari Liljeroos et al. CELLULAR SIGNALLING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started